<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02476448</url>
  </required_header>
  <id_info>
    <org_study_id>FLA 15-015</org_study_id>
    <nct_id>NCT02476448</nct_id>
  </id_info>
  <brief_title>Evaluation of Ureteral Jets on Cystoscopy</brief_title>
  <acronym>JET</acronym>
  <official_title>Evaluation of Ureteral Jets on Cystoscopy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates 4 different methods to aid surgeons visualize ureteral jets on
      cystoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study proposes to test and compare the surgeon's impression/confidence in identifying
      ureteral jets using 3 other methods in contrast to standard diagnostic cystoscopy: 1)
      cystoscopy with Dextrose 10% solution, 2) cystoscopy with phenazopyridine and 3) IV sodium
      fluorescein 4) standard cystoscopy with saline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ureteral Jet Visibility</measure>
    <time_frame>5 minutes</time_frame>
    <description>Surgeons will chose from a likert scales as either:
not visible
Somewhat visible
clearly visible This will be completed during the cystoscopic evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgeon Satisfaction</measure>
    <time_frame>5 mins</time_frame>
    <description>A 4 point likert scale will be completed during the procedure to assess satisfaction as follows:
very satisfied
satisfied
somewhat satisfied
unacceptable</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Urinary tract infections</measure>
    <time_frame>6 weeks</time_frame>
    <description>Medical records will be followed prospectively for 6 weeks to assess for incidence of urinary tract infections within different groups.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">177</enrollment>
  <condition>Injury of Ureter</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infused into the bladder to allow for visualization of bladder walls and urine jets.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose 10%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infused into the bladder to allow for visualization of bladder walls and colored urine jets.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenazopyridine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will be administered (PO) preoperatively and will be evaluated for its colorization properties during cystoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Fluorescein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will be administered (IV) prior to the cystoscopy and will be evaluated for its colorization properties during cystoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Used to distend the bladder for cystoscopic evaluation</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <other_name>Saline</other_name>
    <other_name>NS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenazopyridine</intervention_name>
    <description>Administered orally preoperatively and assessed during cystoscopy</description>
    <arm_group_label>Phenazopyridine</arm_group_label>
    <other_name>Pyridium</other_name>
    <other_name>AZO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextrose 10%</intervention_name>
    <description>Used to distend the bladder for cystoscopic evaluation</description>
    <arm_group_label>Dextrose 10%</arm_group_label>
    <other_name>D10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Fluorescein</intervention_name>
    <description>Administered intravenously and assessed during cystoscopy</description>
    <arm_group_label>Sodium Fluorescein</arm_group_label>
    <other_name>Fluorescein</other_name>
    <other_name>Fluorocyte</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult

          -  undergoing a cystoscopy or as part of their planned procedure

        Exclusion Criteria:

          -  Chronic kidney disease

          -  known prior surgical removal of kidney or ureteral obstruction

          -  Current ureteral stent placed

          -  Allergy to any of the interventions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo Davila, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexandriah Alas, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis M Espaillat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2015</study_first_submitted>
  <study_first_submitted_qc>June 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2015</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>G. Willy Davila</investigator_full_name>
    <investigator_title>Chairman Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>ureteral jet</keyword>
  <keyword>pelvic surgery</keyword>
  <keyword>cystoscopy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

